Glucose monitoring in women with polycystic ovary syndrome
Official title: Glucose Profiles in Women With Polycystic Ovary Syndrome
Run by Centre Hospitalier Universitaire, Amiens · NCT07483723 · Data updated 2026-11-12
This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Salouël) |
| Status | Recruiting |
| Started | January 6, 2026 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07483723 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult women (>18 years) with a clinical diagnosis of PCOS who are not pregnant, agree to wear the FreeStyle Libre Pro sensor, and meet the trial's medication and exclusion criteria are ideal candidates.
✕Probably not a fit
Women with pre-existing diabetes, current pregnancy or breastfeeding, or recent use of excluded hormonal or metabolic treatments are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project uses continuous glucose monitoring to characterize daily glucose patterns in adult women diagnosed with PCOS and to compare these patterns across the four recognized PCOS phenotypes (A–D). Participants will be classified by reproductive and biochemical features (menstrual irregularity, hyperandrogenism, ovarian morphology or AMH levels) and will wear a FreeStyle Libre Pro sensor to collect interstitial glucose readings over the monitoring period. Investigators will analyze glucose parameters such as mean glucose, time-in-range, glycemic variability, and episodes of hyperglycemia, and will compare these metrics between phenotypes while accounting for factors like insulin resistance and BMI. The aim is to determine whether certain PCOS phenotypes have worse glucose profiles that warrant closer metabolic surveillance.
Why it matters
Potential benefit: If successful, the results could identify PCOS phenotypes at higher risk of glucose abnormalities and help target earlier screening or preventive care.
How similar studies have gone: Continuous glucose monitoring has been applied in metabolic research, but few prior studies have directly compared CGM-derived glucose profiles across PCOS phenotypes, so this phenotype-focused approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years at inclusion criteria * Patient with polycystic ovary syndrome, defined by the presence of at least 2/3 irregular menstrual cycles, clinical or biological hyperandrogenism, polycystic ovary morphology (pelvic ultrasound) or elevated AMH levels, after the exclusion of other disorders. * Agreed to carry the FSL pro * Signed informed consent Exclusion Criteria: * Pregnancy, breast-feeding * Differential diagnoses: hyperprolactinemia, dysthyroidism, Cushing's syndrome, congenital adrenal hyperplasia, virilizing tumor (ovarian or adrenal), intake of exogenous androgens * Pre-existing diabetes * Patient treated within 3 months prior to inclusion/data collection with estrogen-progestin contraception, progestin contraception, antidiabetic drugs, inositol, antiandrogen
Where it's running
-
CHRU Amiens
Salouël, France Recruiting
Study contacts
- Study coordinator: Abdallah Al-Salameh, Pr
- Email: Al-Salameh.Abdallah@chu-amiens.fr
- Phone: 33+3.22.08.83.71
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating mitochondrial dysfunction in women with PCOS and infertility
This study is trying to see if problems with energy production in cells are linked to polycystic ovary syndrome (PCOS) and infertility in women.
-
Investigating fasting insulin and insulin resistance across different demographics
This study looks at how fasting insulin levels and insulin resistance vary among different groups of people based on age, sex, race, weight, and conditions like PCOS to better understand metabolic health.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Precision acupuncture and lifestyle for PCOS
This trial tests whether a precision acupuncture approach combined with a personalized lifestyle plan helps improve insulin resistance in people with PCOS compared with conventional acupuncture and standard lifestyle changes.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.